Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-07 Sale | 2026-01-08 4:03 pm | INCYTE CORP | INCY | Issa Mohamed Khairie EVP, Head of US Oncology | 10,856 | $109.07 | $1,184,064 | 66,132 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-16 Option Award | 2026-01-21 4:06 pm | N/A 2036-01-15 | INCYTE CORP | INCY | Issa Mohamed Khairie EVP, Head of US Oncology | 14,237 | $0 | 14,237 (Direct) | View |
| 2026-01-06 Tax Withholding | 2026-01-08 4:03 pm | N/A N/A | INCYTE CORP | INCY | Issa Mohamed Khairie EVP, Head of US Oncology | 8,264 | $106.66 | 66,132 (Direct) | View |
| 2025-07-15 Option Award | 2025-07-17 4:04 pm | N/A 2028-07-15 | INCYTE CORP | INCY | Issa Mohamed Khairie EVP, Head of US Oncology | 50,427 | $0 | 126,910 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-02 4:42 pm | N/A N/A | INCYTE CORP | INCY | Issa Mohamed Khairie EVP, Head of US Oncology | 27,812 | $0 | 76,483 (Direct) | View |
| 2025-01-06 Option Award | 2025-01-08 4:11 pm | N/A N/A | INCYTE CORP | INCY | Issa Mohamed Khairie EVP, Head of US Oncology | 48,671 | $0 | 48,671 (Direct) | View |